Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 12Esophageal Squamous Cell Carcinoma 7Carcinoma, Non-Small-Cell Lung 6Rectal Neoplasms 5Uterine Cervical Neoplasms 4Pancreatic Neoplasms 4Head and Neck Neoplasms 3Glioblastoma 3Brain Neoplasms 3Stomach Neoplasms 2Nasopharyngeal Carcinoma 2Lung Neoplasms 2Hyperthermia 2Anus Neoplasms 2Adenocarcinoma 2Unresectable Stage III NSCLC 1Thymic epithelial tumor 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Recurrence 1Rare Diseases 1Prostatic Neoplasms 1Pleural Effusion, Malignant 1Ovarian Neoplasms 1Neoplasm Metastasis 1Mucositis 1Metastasising Cancer of Unknown Primary 1Medulloblastoma 1Lymphoma, B-Cell, Marginal Zone 1Locally Advanced Rectal Cancer 1

Interventions

dehydroftorafur 1Taxes 1Radiotherapy, Intensity-Modulated 1Radiation 1Platinum 1Paclitaxel 1Immune Checkpoint Inhibitors 1Fluorouracil 1Cisplatin 1Chemoradiotherapy 1Carboplatin 1Capecitabine 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Anal Canal Carcinoma × Radiation × Clear all
NCT05374252 2022-05-16

Chemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma Patients

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 3 Unknown
102 enrolled
Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡